Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Pediatr Pulmonol. 2019 Dec 5;55(2):330–337. doi: 10.1002/ppul.24595

Table 1:

Baseline characteristics of study participants, by asthma status

ALL Controls Cases
N= 638 308 330
Annual 1-hr daily max SO2, ppb 3.80 (0.88) 3.64 (0.57) 3.84 (0.92)**
Age, years 10.2 (2.7) 10.5 (2.7) 10.0 (2.6)*
Gender, female 302 (47%) 158 (51%) 144 (44%)
Lived at current residence, years 7.2 (4.0) 7.6 (4.0) 6.9 (3.9)*
FVC %predicted 103 (17) 105 (18) 102 (16)
FEV1, % predicted 95 (15) 98 (15) 93 (16)**
FEV1/FVC, % predicted 92 (10) 94 (10) 91 (10)**
Income >$15,000, yes 225 (36%) 110 (37%) 115 (35%)
Distance to a major roadway, meters 220 (324) 287 (364) 210 (269)
Current SHS exposure, yes 252 (40%) 104 (34%) 148 (45%)**
IgE, geometric mean 214 (4.9) 151 (4.7) 300 (4.8)**
Atopy 331 (59%) 135 (50%) 196 (69%)**
BMI, z score 0.59 (1.1) 0.49 (1.1) 0.69 (1.2)*
Parental history of asthma, yes 317 (50%) 98 (32%) 219 (67%)**
Parental history of allergic rhinitis, yes 125 (20%) 45 (15%) 80 (24%)**
Prescribed inhaled corticosteroid in last 6 months, yes - - 107 (32%)

Results reported as mean (sd), median (IQR) for SO2 and distance, or n (%). Atopy defined as at least one positive (≥0.35kU/L) specific-IgE to aeroallergen (cat, dog, dust mite, cockroach, mouse). Percent predicted calculated based on Global Lung Initiative (GLI2012) prediction equations. Analysis restricted to participants who reported living at least 1 year at current residence. P value obtained from Wilcoxon rank sum or Chi square between no asthma and asthma groups.

*

p value<0.05,

**

p value <0.01